MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 69 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62 | -1.6% | 48 | 0.0% | 0.00% | – |
| Q2 2023 | $63 | +85.3% | 48 | 0.0% | 0.00% | – |
| Q1 2023 | $34 | -5.6% | 48 | 0.0% | 0.00% | – |
| Q4 2022 | $36 | – | 48 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,220,938 | $16,299,000 | 0.94% |
| Boxer Capital, LLC | 4,029,649 | $10,558,000 | 0.36% |
| DAFNA Capital Management LLC | 199,425 | $522,000 | 0.17% |
| J. Goldman & Co LP | 443,517 | $1,162,000 | 0.08% |
| Ikarian Capital, LLC | 1,196,308 | $688,000 | 0.05% |
| HHLR ADVISORS, LTD. | 1,598,185 | $4,187,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 133,634 | $350,000 | 0.02% |
| F3Logic, LLC | 255 | $668,000 | 0.02% |
| Schonfeld Strategic Advisors LLC | 343,195 | $899,000 | 0.02% |
| CSS LLC/IL | 54,773 | $144,000 | 0.01% |